Table 1:
Measurements of absolute CBFmax and rCBFmax in each type of pathologic tumor
| Grade/Histology | No. | CBFmax (mL/100 g/min) |
rCBFmax | |
|---|---|---|---|---|
| Tumor | Contralateral | |||
| Grade II (n = 13) | ||||
| Astrocytoma | 5 | 75.4 ± 10.2a,b | 83.2 ± 3.90 | 0.91 ± 0.18c,d |
| Oligoastrocytoma | 4 | 74.8 ± 12.1a,b | 93.2 ± 28.8 | 0.83 ± 0.16c,d |
| Oligodendroglioma | 4 | 109.8 ± 47.8e | 80.0 ± 9.6 | 1.38 ± 0.59e,f |
| Grade III (n = 17) | ||||
| Anaplastic astrocytoma | 6 | 127.2 ± 84.8e | 78.0 ± 23.6 | 1.51 ± 0.68e,f |
| Anaplastic oligoastrocytoma | 7 | 125.1 ± 71.9e | 82.4 ± 8.9 | 1.54 ± 0.88e,f |
| Anaplastic oligodendroglioma | 4 | 212.5 ± 87.5 | 78.8 ± 16.6 | 2.75 ± 1.02 |
| Grade IV (n = 28) | ||||
| Glioblastoma | 28 | 171.5 ± 58.7 | 77.0 ± 10.9 | 2.25 ± 0.79 |
a
P < .01, compared with glioblastoma.
b
P < .01, compared with anaplastic oligoastrocytoma.
c
P < .001, compared with glioblastoma.
d
P < .001, compared with anaplastic oligoastrocytoma.
e
P < .05, compared with anaplastic oligoastrocytoma.
f
P < .05, compared with glioblastoma.